Sunscreen Firm Warned, Natural Balms Among Recent Recalls: Consumer Health News
Executive Summary
Korean OTC firm Seidni has GMP, sunscreen labeling problems; DXM abuse by teens remains at 3%, annual survey shows; GMP deviations among reasons behind recent OTC recalls.
You may also be interested in...
States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.